Increasing evidence suggests that the epidermal growth factor receptor (EGFR) and c-Src tyrosine kinase families have critical roles in the development of breast neoplasias. Both families are overexpressed or activated in many breast tumor samples and cell lines. Heterocomplexes have been detected between EGFR (HER-1) and c-Src and between p185neu (HER-2) and c-Src in human breast tumor cell lines and tumor samples. In addition, HER-1 is oncogenic in EGF-stimulated fibroblasts and Src family members are required for EGF-induced mitogenesis. These findings suggest that members of these two families may cooperate during tumor development. The hypothesis was confirmed when overexpression of HER-1 and c-Src in 10T1/2 fibroblasts resulted in a synergistic increase in tumor formation in nude mice. Enhanced tumor formation correlated with heterocomplexes between c-Src and HER-1, novel c-Src-dependent phosphorylations on HER-1 and elevated in vivo tyrosyl phosphorylation of receptor substrates. To study the mechanism of this synergy and how this interaction may be involved in mammary malignancies, it is proposed to examine human breast tumor samples and cell lines for heterocomplex formation between c-Src and HER-1, the presence of novel phosphorylations on the receptor, and enhanced kinase activity. A structure/function analysis of the domains of c-Src and HER-1 that are required for the synergism will be carried out in 10T1/2 cells. Similar studies will be performed with HER-2 and c-Src. Finally, c-Src from a number of tumor samples and cell lines will be examined to determine if established or novel mechanisms of activation are occurring, with the goal of determining whether diagnostic reagents would recognize activated vs. inactivated enzyme.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA071449-03
Application #
2882454
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Gallahan, Daniel L
Project Start
1997-04-16
Project End
2002-01-31
Budget Start
1999-02-02
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Virginia
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Demory, Michelle L; Boerner, Julie L; Davidson, Robert et al. (2009) Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem 284:36592-604
Marozkina, Nadzeya V; Stiefel, Steven M; Frierson Jr, Henry F et al. (2008) MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues. J Cell Biochem 103:2010-8
Ishizawar, R C; Miyake, T; Parsons, S J (2007) c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 26:3503-10
Amorino, G P; Deeble, P D; Parsons, S J (2007) Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene 26:745-56
Riggins, Rebecca B; Thomas, Keena S; Ta, Huy Q et al. (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66:7007-15
Boerner, Julie L; Biscardi, Jacqueline S; Silva, Corinne M et al. (2005) Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis. Mol Carcinog 44:262-73
Boerner, Julie L; Gibson, Matthew A; Fox, Emily M et al. (2005) Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Mol Endocrinol 19:2660-70
Ishizawar, Rumey C; Tice, David A; Karaoli, Themistoclis et al. (2004) The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism. J Biol Chem 279:23773-81
Boerner, Julie L; Demory, Michelle L; Silva, Corinne et al. (2004) Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 24:7059-71
Kloth, Michael T; Laughlin, Kristen K; Biscardi, Jacqueline S et al. (2003) STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor. J Biol Chem 278:1671-9

Showing the most recent 10 out of 18 publications